Shanghai ZJ Bio-Tech Co., Ltd Stock

Equities

688317

CNE100005DB6

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-05-07 pm EDT 5-day change 1st Jan Change
16.63 CNY +0.79% Intraday chart for Shanghai ZJ Bio-Tech Co., Ltd +3.42% -20.73%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2022 2.33B 322M Sales 2023 274M 37.97M Capitalization 4.03B 558M
Net income 2022 760M 105M Net income 2023 -137M -18.96M EV / Sales 2022 1.41 x
Net cash position 2022 3.14B 434M Net cash position 2023 2.76B 382M EV / Sales 2023 4.63 x
P/E ratio 2022
8.5 x
P/E ratio 2023
-29.5 x
Employees 435
Yield 2022
3.59%
Yield 2023
-
Free-Float 55.92%
More Fundamentals * Assessed data
Dynamic Chart
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024. CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shanghai ZJ Bio-Tech Co., Ltd. announces an Equity Buyback for CNY 70 million worth of its shares. CI
Shanghai ZJ Bio-Tech Co., Ltd. authorizes a Buyback Plan. CI
Certain A Shares of Shanghai ZJ Bio-Tech Co., Ltd. are subject to a Lock-Up Agreement Ending on 19-JAN-2024. CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai ZJ Bio-Tech Chairman to Buy 15 Million Yuan More Shares MT
Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback announced on May 6, 2022 has expired. CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022. CI
Shanghai ZJ Bio-Tech Co., Ltd.(XSSC:688317) added to S&P Global BMI Index CI
More news
1 day+0.79%
1 week+3.42%
Current month+3.42%
1 month+8.34%
3 months+6.13%
6 months-29.35%
Current year-20.73%
More quotes
1 week
16.12
Extreme 16.12
16.88
1 month
13.75
Extreme 13.75
16.88
Current year
12.58
Extreme 12.58
21.20
1 year
12.58
Extreme 12.58
28.32
3 years
12.58
Extreme 12.58
79.36
5 years
12.58
Extreme 12.58
93.80
10 years
12.58
Extreme 12.58
93.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 05-04-17
Director of Finance/CFO 43 05-03-31
Corporate Officer/Principal 44 06-06-30
Members of the board TitleAgeSince
Director/Board Member 55 20-05-21
Director/Board Member 47 20-05-21
Chief Executive Officer 53 05-04-17
More insiders
Date Price Change Volume
24-05-08 16.63 +0.79% 2,759,044
24-05-07 16.5 +0.43% 1,798,512
24-05-06 16.43 +2.18% 2,569,267
24-04-30 16.08 +0.37% 1,984,086

End-of-day quote Shanghai S.E., May 07, 2024

More quotes
Shanghai ZJ Bio-Tech Co Ltd is a China-based company that mainly engaged in the production of molecular diagnostic reagents. The Company is mainly engaged in the research, development, production and sales of genetic diagnostic reagents and equipment. The Company's main products include nucleic acid detection kits and molecular diagnostic instruments. The Company's products are mainly used in areas such as emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The Company mainly conducts business within the domestic market.
More about the company
  1. Stock Market
  2. Equities
  3. 688317 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW